Portfolio Management Services (PMS)
Compare Schemes

Northern Arc Credit Opportunities Strategy vs Valcreate Lifesciences and Specialty Opportunities

Northern Arc Credit Opportunities Strategy
Valcreate Lifesciences and Specialty Opportunities
Add Scheme
Return for the risk
3 yrs return
15%
20%
25%
10%
20%
30%
Volatility • 3 yrs deviation
1 Month
1.23%
6.35%
6 Months
5.08%
17.95%
1 Year
12.24%
21.71%
3 Years
—
19.34%
5 Years
—
—
Since Inception
11.71%
19.34%
Fund Age
2 yrs 7 mo
3 yrs 6 mo
AUM
₹6.47 Cr
₹18.73 Cr
Alpha – 1 Year
2.34%
16.99%
Alpha – 3 Years
—
7.25%
Information Ratio – 3 Years
—
0.85
Volatility – 1 Year
1.78%
22.22%
Volatility – 3 Years
—
20.72%
Beta – 1 Year
0.39
0.87
Beta – 3 Years
—
0.89
Sharpe Ratio – 1 Year
3.43
0.75
Sharpe Ratio – 3 Years
—
0.85
Worst Rolling Year
—
—
Value at Worst Rolling Year
—
—
Deepest Drawdown
—
—
Recovery Period
—
—
1-Year Rolling Windows Positive
—
—
Median Rolling Year
—
—
5-Year Rolling Windows Positive
—
—
Market-Cap Mix
—
—
Number of Stocks
1
—
Portfolio P/E
—
—
Top 5 Holdings
MIDLAND MICROFIN LIMITED · 52.82%
Spandana Sphoorty Financial Limited · 29.77%
Indel Money Ltd. 11% DB REDEEM 07/10/2026 INR 100000 · 13.05%
Krazybee Services Private Limited · 4.36%
Sharda Cropchem Ltd · 11.13%
Kwality Pharmaceuticals Ltd · 5.72%
Sumitomo Chemical India Ltd · 5.72%
Vinati Organics Ltd · 5.51%
Rallis India Ltd · 5.34%
Top Sectors
Others · 13.05%
—
Fixed Fee
—
2.50% / yr
Performance Fee / Plan
—
Fixed Plan
Exit Load (Y1 / Y2 / Y3)
—
0% / 0% / 0%
Let's start a
conversation
  • Compare this PMS against 3,000+ others with our research desk
  • Build a long-term portfolio around your goals, not a one-off buy
  • Experts with decades of experience.
Private. Personal. No obligation.
We will only use these details to contact you about this enquiry. No spam.
Start a conversation
Share a few details and an expert will reach out.
We will only use these details to contact you about this enquiry. No spam.